Endo to acquire American Medical Systems

Keith Moore | | Health Exec | Digital Transformation
Endo Pharmaceuticals and American Medical Systems (AMS) announced that they have entered into a definitive agreement.

Accoding to the agreement, Endo will acquire AMS, a Minnetonka, Minn.-based provider of devices and therapies for male and female pelvic health, for $30 per share, or $2.9 billion in cash, which includes the assumption and repayment of $312 million of AMS debt.

Endo has fully committed financing in place to complete the transaction, according to the Newark, Del.-based company.

Keith Moore

Related Content

AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan
4 points crucial to the nimble regulation of GenAI
5 tips to learn AI from scratch and for free
Good AI governance can spell the difference between smashing success and mere learning experience

Around the web

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

Cardiovascular Business
FDA commissioner urges clinicians to join fight against medical misinformation

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Design by Adaptive Theme
Trimed Popup
Trimed Popup